GRANISETRON HYDROCHLORIDE

Search structure
Trade Names:
Synonyms:
Status: Approved (1993)
Entry Type: Small molecule
Molecule Category: Salt
UNII: 318F6L70J8
Parent Compound: GRANISETRON

Structure
InChI Key QYZRTBKYBJRGJB-UHFFFAOYSA-N
Smile CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2.Cl
InChI
InChI=1S/C18H24N4O.ClH/c1-21-13-6-5-7-14(21)11-12(10-13)19-18(23)17-15-8-3-4-9-16(15)22(2)20-17;/h3-4,8-9,12-14H,5-7,10-11H2,1-2H3,(H,19,23);1H

Physicochemical Descriptors

Property Name Value
Molecular Formula C18H25ClN4O
Molecular Weight 348.88
AlogP 2.32
Hydrogen Bond Acceptor 4.0
Hydrogen Bond Donor 1.0
Number of Rotational Bond 2.0
Polar Surface Area 50.16
Molecular species BASE
Aromatic Rings 2.0
Heavy Atoms 23.0

Pharmacology

Action Mechanism of Action Reference
ANTAGONIST Serotonin 3a (5-HT3a) receptor antagonist DailyMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Nausea 4 D009325 ClinicalTrials
Nausea 4 D009325 ClinicalTrials
Postoperative Nausea and Vomiting 4 D020250 ClinicalTrials
Neoplasms 3 D009369 ClinicalTrials
Sepsis 2 D018805 ClinicalTrials

Related Entries

Scaffolds

Parent

Adverse Reactions

SOC By Demographic Distribution
System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
21.38
Gastrointestinal disorders
13.98
Respiratory, thoracic and mediastinal disorders
7.48
Nervous system disorders
6.89
Skin and subcutaneous tissue disorders
5.48
Musculoskeletal and connective tissue disorders
5.45
Injury, poisoning and procedural complications
5.14
Cardiac disorders
4.88
Vascular disorders
4.18
Metabolism and nutrition disorders
4.0
Blood and lymphatic system disorders
3.95
Investigations
3.53
Psychiatric disorders
3.04
Infections and infestations
2.92

Cross References

Resources Reference
ChEMBL CHEMBL1237080
FDA SRS 318F6L70J8
PubChem 6918003
SureChEMBL SCHEMBL33433
CONTENTS